Molecular cloning and characterization of a novel retinoblastoma- binding protein

Genomics

Volumn 51, Issue 3, 1998, Pages 351-358

  Fusco, Carlo ^a   Reymond, Alexandre ^a   Zervos, Antonis S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; RETINOBLASTOMA PROTEIN;

ARTICLE; CHROMOSOME 18Q; GENE ISOLATION; GENE LOCATION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINOBLASTOMA;

MAMMALIA;

EID: 0032144027     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1998.5368     Document Type: Article

References (48)

1. Adnane J., Shao Z., Robbins P. D. The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter. J. Biol. Chem. 270:1995;8837-8843.
2. Altschul S. F., Gish W., Miller W., Myers E., Lipman D. J. Basic local alignment search tool. J. Mol. Biol. 215:1990;403-410.
3. Altschul S. F., Madden T. L., Schaffer A. A., Zhang J., Zhang Z., Miller W., Lipman D. J. Gapped BLAST and PSI BLAST: A new generation of protein database search programs. Nucleic Acids Res. 25:1997;3389-3402.
4. Bagchi S., Raychaudhuri P., Nevins J. R. Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: A novel mechanism for E1A trans-activation. Cell. 62:1990;659-669.
5. Bandara L. R., La Thangue N. B. Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature. 351:1991;494-497.
6. Bao J., Zervos A. S. Isolation and characterization of Nmi, a novel partner of Myc proteins. Oncogene. 12:1996;2171-2176.
7. Blackwood E. M., Eisenman R. N. Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with myc. Science. 251:1991;1211-1217.
8. Boyd J. M., Subramanian T., Schaeper U., Regina M. L., Bayley S., Chinnadurai G. A region in the C terminus of adenovirus 2/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24 ras mediated transformation, tumorigenesis and metastasis. EMBO J. 12:1993;469-478.
9. Brent R., Finley R. L. Jr. Understanding gene and allele function with two-hybrid methods. Annu. Rev. Genet. 31:1997;663-704.
10. Buchkovich K., Duffy L. A., Harlow E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell. 58:1989;1097-1105.
11. Chellappan S. P., Hiebert S., Mudryj M., Horowitz J. M., Nevins J. R. The E2F transcription factor is a cellular target for the RB protein. Cell. 65:1991;1053-1061.
12. Chen P. L., Scully P., Shew J. Y., Wang J. Y., Lee W. H. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell. 58:1989;1193-1198.
13. Cobrinik D., Dowdy S. F., Hinds P. W., Mittnacht S., Weinberg R. A. The retinoblastoma protein and the regulation of cell cycling. Trends Biochem. Sci. 17:1992;312-315.
14. DeCaprio J. A., Ludlow J. W., Lynch D., Furukawa Y., Griffin J., Piwnica-Worms H., Huang C. M., Livingston D. M. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell. 58:1989;1085-1095.
15. Estojak J., Brent R., Golemis E. A. Correlation of two-hybrid affinity data within vitro. Mol. Cell. Biol. 15:1995;5820-5829.
16. Ewen M. The cell cycle and the retinoblastoma protein family. Cancer Metastasis Rev. 13:1994;45-66.
17. Figge J., Webster T., Smith T. F., Paucha E. Prediction of similar transforming regions in simian virus 40 large T, adenovirus E1A, and myc oncoproteins. J. Virol. 62:1988;1814-1818.
18. Finley R. L. Jr., Brent R. Interaction mating reveals binary and ternary connections betweenDrosophila. Proc. Natl. Acad. Sci. USA. 91:1994;12980-12984.
19. Friend S. H., Bernards R., Rogelj S., Weinberg R. A., Rapaport J. M., Albert D. M., Dryja T. P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 323:1986;643-646.
20. Gyuris J., Golemis E., Chertkov H., Brent R. Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell. 75:1993;791-803.
21. Heng H. H. Q., Squire J., Tsui L.-C. High resolution mapping of mammalian genes by in situ hybridization to free chromatin. Proc. Natl. Acad. Sci. USA. 89:1992;9509-95013.
22. Heng H. H. Q., Tsui L.-C. Modes of DAPI banding and simultaneous in situ hybridization. Chromosoma. 102:1993;325-332.
23. Heng H. H. Q., Tsui L.-C. FISH Detection of DAPI Banded Chromosomes. 1994;Humana Press, Clifton.
24. Hu Q. J., Bautista C., Edwards G. M., Defeo-Jones D., Jones R. E., Harlow E. Antibodies specific for the human retinoblastoma protein identify a family of related polypeptides. Mol. Cell. Biol. 11:1991;5792-5799.
25. Hurlin P. J., Queva C., Koskinen P. J., Steingrimsson E., Ayer D. E., Copeland N. G., Jenkins N. A., Eisenman R. N. Mad3 and Mad4: Novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J. 14:1995;5646-5659.
26. Knudsen E. S., Wang J. Y. Dual mechanisms for the inhibition of E2F binding to RB by cyclin dependent kinase mediated RB phosphorylation. Mol. Cell. Biol. 17:1997;5771-5783.
27. Lees J. A., Buchkovich K. J., Marshak D. R., Anderson C. W., Harlow E. The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J. 10:1991;4279-4290.
28. Ludlow J. W., Shon J., Pipas J. M., Livingston D. M., DeCaprio J. A. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell. 60:1990;387-396.
29. Lupas A., Dyke M. V., Stock J. Predicting coiled coils from protein sequences. Science. 252:1991;1162-1164.
30. Luscher B., Eisenman R. N. New light on myc and myb. Part I. Myc. Genes Dev. 4:1990;2025-2035.
31. Mihara K., Cao X. R., Yen A., Chandler S., Driscoll B., Murphree A. L., T'Ang A., Fung Y. K. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science. 246:1989;1300-1303.
32. Nakai K. Predicting various targeting signals in amino acid sequences. Bull. Inst. Chem. Res. Kyoto Univ. 1991.
33. Paggi M. G., Baldi A., Bonetto F., Giordano A. Retinoblastoma protein family in cell cycle and cancer: A review. J. Cell. Biochem. 62:1996;418-430.
34. Pear W. S., Nolan G. P., Scott M. L., Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA. 90:1993;8392-8396.
35. Schaeper U., Boyd J. M., Verma S., Uhlmann E., Subramanian T., Chinnadurai G. Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc. Natl. Acad. Sci. USA. 92:1995;10467-10471.
36. Schaeper U., Subramanian T., Lim L., Boyd J. M., Chinnadurai G. Interaction between a cellular protein that binds to the C-terminal region of adenovirus E1A (CtBP) and a novel cellular protein is distrupted by E1A through a conserved PLDLS motif. J. Biol. Chem. 273:1998;8549-8552.
37. Sellers W. R., Rodgers J. W., Kaelin W. G. Jr. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl. Acad. Sci. USA. 92:1995;11544-11548.
38. Sollerbrant K., Chinnadurai G., Svensson C. The CtBP binding domain in the adenovirus E1A protein controls CR1 dependent transactivation. Nucleic Acids Res. 24:1996;2578-2584.
39. Taya Y. RB kinases and RB binding proteins: New points of view. Trends Biochem. Sci. 22:1997;14-17.
40. Thomas B. J., Zavitz K. H., Dong X., Lane M. E., Weigmann K., Finley R. L. Jr., Brent R., Lehner C. F., Zipursky S. L. Roughex down-regulates G2 cyclins in G1. Genes Dev. 11:1997;1289-1298.
41. Weinberg R. A. The retinoblastoma gene and gene product. Cancer Surveys. 12:1992;43-57.
42. Weinberg R. A. The retinoblastoma protein and cell cycle control. Cell. 81:1995;323-330.
43. Weintraub S. J., Chow K. N., Luo R. X., Zhang S. H., He S., Dean D. C. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature. 375:1995;812-815.
44. Weintraub S. J., Prater C. A., Dean D. C. Retinoblastoma protein switches the E2F site from positive to negative element. Nature. 358:1992;259-261.
45. Whyte P., Buchkovich K. J., Horowitz J. M., Friend S. H., Raybuck M., Weinberg R. A., Harlow E. Association between an oncogene and an anti-oncogene: The adenovirus E1A proteins bind to the retinoblastoma gene product. Nature. 334:1988;124-129.
46. Yen A., Coder D., Varvayanis S. Concentration of RB protein in nucleus vs. cytoplasm is stable as phosphorylation of RB changes during the cell cycle and differentiation. Eur. J. Cell Biol. 72:1997;159-165.
47. Zervos A. S., Faccio L., Gatto J., Kyriakis J. M., Brent R. Mxi2, a MAP kinase that recognizes and phosphorylates Max protein. Proc. Natl. Acad. Sci. USA. 92:1995;10531-10534.
48. Zervos A. S., Gyuris J., Brent R. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition site. Cell. 72:1993;223-232.